Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 16/20 | 0.49 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.46 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.46 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | TDO2 | P48775 | 1/20 | 0.43 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7476736 | 1.00 | TACR1 (0.49) | TACR1CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL5418286 | 0.79 | CHRNB2 (0.53) | TACR1IDO1 | |
| SCHEMBL14945152 | 0.79 | CHRNB2 (0.53) | TACR1IDO1 | |
| SCHEMBL6959276 | 0.74 | TACR1 (0.45) | TACR1 | |
| SCHEMBL6997883 | 0.73 | TACR1 (0.63) | TACR1CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7000528 | 0.73 | TACR1 (0.63) | TACR1CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL6482147 | 0.73 | TACR1 (0.67) | TACR1 | |
| SCHEMBL6483982 | 0.73 | TACR1 (0.67) | TACR1 | |
| SCHEMBL6483987 | 0.73 | TACR1 (0.67) | TACR1 | |
| SCHEMBL6495575 | 0.73 | TACR1 (0.67) | TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165540-A1 | TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | MERCK SHARP & DOHME LTD. (GB) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000056727-A1 | TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | MERCK SHARP & DOHME LIMITED (GB) | 2000-09-28 | — | — | WO | disclosed |